Adaptin Bio, Inc.
APTN
$6.20
$0.000.00%
OTC PK
| 03/31/2026 | 12/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | 26.27% | -13.59% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -16.36% | -18.36% | |||
| Operating Income | 16.36% | 18.36% | |||
| Income Before Tax | 16.22% | 18.36% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 16.22% | 18.36% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 16.22% | 18.36% | |||
| EBIT | 16.36% | 18.36% | |||
| EBITDA | -- | -- | |||
| EPS Basic | 18.35% | 18.62% | |||
| Normalized Basic EPS | 18.35% | 18.64% | |||
| EPS Diluted | 18.65% | 19.05% | |||
| Normalized Diluted EPS | 18.35% | 18.64% | |||
| Average Basic Shares Outstanding | 2.58% | 0.32% | |||
| Average Diluted Shares Outstanding | 2.58% | 0.32% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||